D, B., R, S., M, G., J, L., & CC, L. W. (2022). Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 28(11), 1166. https://doi.org/10.1016/j.eprac.2022.07.014
Chicago Style (17th ed.) CitationD, Brooks, Schulman-Rosenbaum R, Griff M, Lester J, and Low Wang CC. "Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 28, no. 11 (2022): 1166. https://doi.org/10.1016/j.eprac.2022.07.014.
MLA (9th ed.) CitationD, Brooks, et al. "Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 28, no. 11, 2022, p. 1166, https://doi.org/10.1016/j.eprac.2022.07.014.
